Recruiting
Phase 1

SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects

Sponsor:

PYC Therapeutics

Code:

NCT05902962

Conditions

Retinal Dystrophy

PRPF31 Mutationassociated Retinal Dystrophy

RP11

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VP-001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information